Polyoxometalates: Introduction to a class of inorganic compounds and their biomedical applications

Frontiers in Bioscience

Volumn 10, Issue 1, 2005, Pages 275-287

  Hasenknopf, Bernold ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b CNRS   (France)

Author keywords

Cancer; Infections; Polyoxomolybdates; Polyoxotungstates; Polyoxovanadates; Review

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; FLUOROURACIL; INORGANIC COMPOUND; METICILLIN; MOLYBDENUM COMPLEX; NIMUSTINE; OXACILLIN; PENICILLIN G; TUNGSTEN DERIVATIVE; VANADIUM DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER INHIBITION; CELL TRANSPORT; COLON CANCER; DIABETES MELLITUS; DRUG EFFICACY; DRUG SYNTHESIS; DRUG TRANSPORT; DRUG UPTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; LUNG CANCER; NONHUMAN; PARTICLE SIZE; REVIEW; SARCOMA; TUMOR VOLUME;

ANIMALIA;

EID: 17444408134     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1527     Document Type: Review

References (110)

1. Baker, L. C. W. and D. C. Glick: Present General Status of Understanding of Heteropoly Electrolytes and a Tracing of Some Major Highlights in the History of Their Elucidation. Chemical Reviews 98, 3-49 (1998)
2. Pope, M. T: Heteropoly and Isopoly Oxometalates. Springer Verlag, Berlin, (1983)
3. Pope, M. T. and A. Müller: Polyoxometalates: From Platonic Solids to Anti-Retroviral Activity. Kluwer Academic Publishers, Dordrecht.(1994)
4. Pope, M. T. and A. Müller: Polyoxometalate Chemistry: From Topology via Self-Assembly to Applications. Kluwer Academic Publishers, Dordrecht (2001)
5. Polyoxometalate Molecular Science. Eds: J. J. Borras-Almenar, E. Coronado, A. Müller and M. T. Pope, Kluwer Academic Publishers, Dordrecht (2003)
6. Casan Pastor, N. and P. Gomez Romero: Polyoxometalates: From Inorganic Chemistry to Materials Science. Frontiers in Bioscience 9, 1759-1770 (2004)
7. Special issue on polyoxometalates: Polyoxometalates. Chemical Reviews 98 (1998)
8. Guo, Z. and P. J. Sadler: Medicinal inorganic chemistry. Advances in Inorganic Chemistry 49, 183-306 (2000)
9. Tajima, Y: A review of the biological and biochemical effects of tungsten compounds. Current Topics in Biochemical Research 4, 129-136 (2001)
10. Rhule, J. T., C. L. Hill, D. A. Judd and R. F. Schinazi: Polyoxometalates in Medicine. Chemical Reviews 98, 327-357 (1998)
11. Souchay, P: Polyanions et Polycations. Gauthiers-Villars, Paris (1963)
12. Souchay, P: Ions Minéraux Condensés. Masson, Paris (1969)
13. Jolivet, J.-P: Metal Oxide Chemistry and Synthesis: From Solution to Solid State. John Wiley & Sons, New York (2001)
14. Pope, M. T: Molybdenum Oxygen Chemistry: Oxides, Oxo Complexes, and Polyoxoanions. In: Progress in Inorganic Chemistry. Ed: S. J. Lippard, John Wiley & Sons, New York, 181-255 (1991)
15. Hervé, G., A. Tézé and R. Contant: General Principles of the Synthesis of Polyoxometalates in Aqueous Solution. In: Polyoxometalate Molecular Science. Eds: J. J. Borras-Almenar, E. Coronado, A. Müller and M. T. Pope, Kluwer Academic Publishers, Dordrecht, 33-54 (2003)
16. Errington, R. J: General Strategies for Non-Aqueous Polyoxometalate Synthesis. In: Polyoxometalate Molecular Science. Eds: J. J. Borras-Almenar, E. Coronado, A. Müller and M. T. Pope, Kluwer Academic Publishers, Dordrecht, 55-78 (2003)
17. Klemperer, W. G: Early Transition Metal Polyoxoanions. In: Inorganic Syntheses. Ed. A. P. Ginsberg, John Wiley & Sons, New York, 71-135 (1990)
18. Müller, A. and P. Kögerler: From simple building blocks to structures with increasing size and complexity. Coordination Chemistry Reviews 182, 3-17 (1999)
19. Pope, M. T: Introduction to Polyoxometalate Chemistry. In: Polyoxometalate Molecular Science. Eds: J. J. Borras-Almenar, E. Coronado, A. Müller and M. T. Pope, Kluwer Academic Publishers, Dordrecht, 3-31 (2003)
20. Hill, C. L: Stable, self-assembling, equilibrating catalysts for green chemistry. Angewandte Chemie, International Edition 43, 402-404 (2004)
21. 5,6- (X = P, Si). Journal of the American Chemical Society 120, 10254-10255 (1998)
22. Bareyt, S., S. Piligkos, B. Hasenknopf, P. Gouzerh, E. Lacôte, S. Thorimbert and M. Malacria: Highly efficient peptide bond formation to functionalized Wells-Dawson-type polyoxotungstates. Angewandte Chemie, International Edition 42, 3404-3406 (2003)
23. Gouzerh, P. and A. Proust: Main-Goup Element, Organic, and Organometallic Derivatives of Polyoxometalates. Chemical Reviews 98, 77-112 (1998)
24. Hasenknopf, B., R. Delmont, P. Herson and P. Gouzerh: Anderson-type heteropolymolybdates containing tris(alkoxo) ligands: Synthesis and structural characterization. European Journal of Inorganic Chemistry 1081-1087 (2002)
25. 4-. Inorganic Chemistry 38, 6152-6158 (1999)
26. 3-. Inorganic Chemistry 39, 4735-4740 (2000)
27. Kortz, U., J. Vaissermann, R. Thouvenot and P. Gouzerh: Heteropolymolybdates of Phosphate, Phosphonate, and Phosphite Functionalized by Glycine. Inorganic Chemistry 42, 1135-1139 (2003)
28. 2Ar)]. European Journal of Inorganic Chemistry 2757-2766 (2003)
29. Proust, A., R. Villanneau, R. Delmont, V. Artero and P. Gouzerh: Organometallic oxometal clusters. In: Polyoxometalate Chemistry. Eds: M. T. Pope and A. Müller, Kluwer Academic Publishers, Dordrecht, 55-67 (2001)
30. Chermann, J. C., M. Raynaud, C. Jasmin and G. Mathé: Powerful new inhibitor of murine leukaemia and sarcoma viruses. Nature 227, 173-174 (1970)
31. Raynaud, M., J.-C. Chermann, C. Jasmin and G. Mathé: Propriétés d'un inhibiteur très actif des virus leucémogènes murins. Comptes Rendus Hebdomadaires Des Séances De L'Academie Des Sciences. D: Sciences Naturelles 270, 578-580 (1970)
32. Raynaud, M., J.-C. Chermann, F. Plata, C. Jasmin and G. Mathé: Inhibiteurs des virus du groupe leucémiesarcome murins. Silicotungstates. Comptes Rendus Hebdomadaires Des Séances De L'Academie Des Sciences. D: Sciences Naturelles 272, 347-348 (1971)
33. Bonissol, C., P. Kona, J. C. Chermann, C. Jasmin and M. Raynaud: Antiviral action of condensed mineral polyanions. In vitro inhibition of rubella virus. Comptes Rendus Hebdomadaires Des Séances De L'Academie Des Sciences. D: Sciences Naturelles 274, 3030-3033. (1972)
34. Raybaud, N., C. Jasmin, J. Huppert, J. C. Chermann, G. Mathé and M. Raynaud: Study of antivirus activity of mineral condensed polyanions. II. Effect on vesicular stomatitis virus. Revue européenne d'études cliniques et biologiques 17, 295-299. (1972)
35. Haapala, D. K., C. Jasmin, F. Sinoussi, J. C. Chermann and M. Raynaud: Inhibition of tumor virus RNA-dependent DNA polymerase by the heteropolyanion silicotungstate. Biomedicine 19, 7-11 (1973)
36. Jasmin, C., N. Raybaud, J. C. Chermann, D. Haapala, F. Sinoussi, C. B. Loustau, C. Bonissol, P. Kona and M. Raynaud: In vitro effects of silicotungstate on some RNA viruses. Biomedicine 18, 319-327 (1973)
37. Jasmin, C., J. C. Chermann, N. Raybaud, D. Bucchini, O. Jarrett, M. Raynaud, G. Mathé and F. Plata: Effects of STAS JLSV5 and silicotungstate on the replication of murine sarcoma virus (Moloney) and poliovirus. Bibliotheca Haematologica 39, 381-388 (1973)
38. Larnicol, N., Y. Augery, C. Le Bousse-Kerdiles, V. Degiorgis, J. C. Chermann, A. Tézé and C. Jasmin: In vivo effect of a new mineral condensed ion (HPA 39) on murine Friend leukemia. Journal of General Virology 55, 17-23 (1981)
39. Jasmin, C., J. C. Chermann, G. Herve, A. Teze, P. Souchay, C. Boy-Loustau, N. Raybaud, F. Sinoussi and M. Raynaud: In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2- antimonate. Journal of the National Cancer Institute (19401978) 53, 469-474 (1974)
40. Chermann, J. C., F. C. Sinoussi and C. Jasmin: Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2- antimoniate. Biochemical and Biophysical Research Communications 65, 1229-1236 (1975)
41. Raybaud, N., J. C. Chermann, F. C. Sinoussi, Y. Augery and C. Jasmin: Studies on the mechanism of action of ammonium-5-tungsto-2-antimoniate (HPA 23). Bibliotheca Haematologica 504-507 (1975)
42. Werner, G. H., C. Jasmin and J. C. Chermann: Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice. Journal of General Virology 31, 59-64 (1976)
43. Tsiang, H., P. Atanasiu, J. C. Chermann and C. Jasmin: Inhibition of rabies virus in vitro by the ammonium-5-tungsto-2-antimoniate. Journal of General Virology 40, 665-668 (1978)
44. Souyri-Caporale, M., M. G. Tovey, K. Ono, C. Jasmin and J. C. Chermann: Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine. Journal of General Virology 65, Pt 4, 831-835 (1984)
45. Rozenbaum, W., D. Dormont, B. Spire, E. Vilmer, M. Gentilini, C. Griscelli, L. Montagnier, F. Barre-Sinoussi and J. C. Chermann: Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet 1, 450-451 (1985)
46. Rhule, J. T., C. L. Hill, Z. Zheng and R. F. Schinazi: Polyoxometalates and fullerenes as antiHIV agents. Topics in Biological Inorganic Chemistry 2, 117-137 (1999)
47. Witvrouw, M., H. Weigold, C. Pannecouque, D. Schols, E. De Clercq and G. Holan: Potent Anti-HIV (Type 1 and Type 2) Activity of Polyoxometalates: Structure-Activity Relationship and Mechanism of Action. Journal of Medicinal Chemistry 43, 778-783 (2000)
48. Shigeta, S., S. Mori, E. Kodama, J. Kodama, K. Takahashi and T. Yamase: Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates. Antiviral Research 58, 265-271 (2003)
49. Judd, D. A., J. H. Nettles, N. Nevins, J. P. Snyder, D. C. Liotta, J. Tang, J. Ermolieff, R. F. Schinazi and C. L. Hill: Polyoxometalate HIV-1 protease inhibitors. A new mode of protease inhibition. Journal of the American Chemical Society 123, 886-897 (2001)
50. Yamamoto, N., D. Schols, E. De Clercq, Z. Debyser, R. Pauwels, J. Balzarini, H. Nakashima, M. Baba and M. Hosoya: Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents. Molecular Pharmacology 42, 1109-1117 (1992)
51. Yamase, T: Polyoxometalates for molecular devices: antitumor activity and luminescence. Molecular Engineering 3, 241-262 (1993)
52. Yamase, T., H. Fujita, K. Fukushima and Y. Seto: In: PCT Int. Appl 68, Terumo Corp., Japan, Wo, (1988)
53. Yamase, T., H. Fujita and K. Fukushima: Medical chemistry of polyoxometalates. Part 1. Potent antitumor activity of polyoxomolybdates on animal transplantable tumors and human cancer xenograft. Inorganica Chimica Acta 151, 15-18 (1988)
54. Fujita, H., T. Fujita, T. Sakurai, T. Yamase and Y. Seto: Antitumor activity of new antitumor substance, polyoxomolybdate, against several human cancers in athymic nude mice. Tohoku Journal of Experimental Medicine 168, 421-426 (1992)
55. Tomita, K., T. Yamase and K. Shishido: Medical chemistry of polyoxometalates. Part 2. Enzymatic study on binding of heptamolybdate to DNA. Inorganica Chimica Acta 157, 167-169 (1989)
56. Yamase, T: Anticancer agents containing heteropolytungstate ethers. Jpn. Kokai Tokkyo Koho, Terumo Corp., Japan, Jp 02204416, (1990)
57. Yamase, T: Heteropolyacid salt esters as antitumor agents. Jpn. Kokai Tokkyo Koho, Terumo Corp., Japan, Jp 02083328, (1990)
58. Yamase, T., H. Fujita, K. Fukushima and T. Sakurai: Anticancer agents containing heteropolytungstates. Jpn. Kokai Tokkyo Koho, Terumo Corp., Japan, Jp 02204415, (1990)
59. Yamase, T., H. Fujita, K. Fukushima and T. Sakurai: Heteropolyacid salts as antitumor agents. Jpn. Kokai Tokkyo Koho, Terumo Corp., Japan, Jp 02088524, (1990)
60. 25- and their biological activity. Polyhedron 17, 1541-1546 (1998)
61. Wang, X.-H., J.-F. Liu, Y.-G. Chen, Q. Liu, J.-T. Liu and M. T. Pope: Synthesis, characterization and biological activity of organotitanium substituted heteropolytungstates. Dalton 1139-1142 (2000)
62. Wang, X., J. Liu and J. Li: Synthesis, characterization and in vitro antitumor activity of diorganometallo complexes gamma-Keggin anions. Inorganic Chemistry Communications 4, 372-374 (2001)
63. Wang, X.-H., H.-C. Dai and J.-F. Liu: Synthesis, properties and biological activity of organotin decatungstophosphates, Part 2. Transition Metal Chemistry 24, 600-604 (1999)
64. Wang, X., J. Liu and M. T. Pope: New polyoxometalate/starch nanomaterial: synthesis, characterization and antitumoral activity. Dalton Transactions 957-960 (2003)
65. 5). Journal of Inorganic Biochemistry 94, 279-284 (2003)
66. Wang, X. H. and J. F. Liu: Synthesis and characterization of organotin substituted heteropolytungstophosphates and their biological activity. Journal of Coordination Chemistry 51, 73-82 (2000)
67. Wang, X. H., H. C. Dai and J. F. Liu: Synthesis and characterization of organotin-substituted heteropoly tungstosilicates and their biological activity I. Polyhedron 18, 2293-2300 (1999)
68. Wang, X., J. Li, J. He and J. Liu: Synthesis, properties and biological activity of organotitanium substituted heteropolytungstates. Metal-Based Drugs 8, 179-182 (2001)
69. Material and Safety Data Sheet, http://www.sigmaaldrich.com (Accessed: July 14, 2004)
70. Tajima, Y., Z. Nagasawa and J. Tadano: A factor found in aged tungstate solution enhanced the antibacterial effect of beta-lactams on methicillin-resistant Staphylococcus aureus. Microbiology and Immunology 37, 695-703 (1993)
71. Tajima, Y., Z. Nagasawa, I. Tanabe, K. Kusaba and J. Tadano: Possible mechanism of action of beta-lactam-enhancing factor on methicillin-resistant Staphylococcus aureus. Microbiology and Immunology 38, 639-648 (1994)
72. Tajima, Y: Purification of a factor that enhances the antibacterial activity of beta-lactams against methicillin-resistant Staphylococcus aureus: its identification as undecaphosphotungstate. Journal of Inorganic Biochemistry 68, 93-99 (1997)
73. Yamase, T., N. Fukuda and Y. Tajima: Synergistic effect of polyoxotungstates in combination with beta-lactam antibiotics on antibacterial activity against methicillin-resistant Staphylococcus aureus. Biological & Pharmaceutical Bulletin 19, 459-465 (1996)
74. Fukuda, N., T. Yamase and Y. Tajima: Inhibitory effect of polyoxotungstates on the production of penicillin-binding proteins and beta-lactamase against methicillin-resistant Staphylococcus aureus. Biological & Pharmaceutical Bulletin 22, 463-470 (1999)
75. Tajima, Y: Lacunary-substituted undecatungstosilicates sensitize methicillin-resistant Staphylococcus aureus to beta-lactams. Biological & Pharmaceutical Bulletin 24, 1079-1084 (2001)
76. Tajima, Y: The sensitizing effects of undecatungstocobalto(II)silicate on methicillin-resistant Staphylococcus aureus to beta-lactams. Biomedical Research 23, 115-125 (2002)
77. Tajima, Y: Effects of tungstosilicate on strains of methicillin-resistant Staphylococcus aureus with unique resistant mechanisms. Microbiology and Immunology 47, 207-212 (2003)
78. Davies, J. W. and J. F. Collins: The induction of Bacillus licheniformis penicillinase by vanadate, molybdate and tungstate anions. Biochimica Et Biophysica Acta 217, 552-554 (1970)
79. Fukuda, N. and T. Yamase: In vitro antibacterial activity of vanadate and vanadyl compounds against Streptococcus pneumoniae. Biological & Pharmaceutical Bulletin 20, 927-930 (1997)
80. Yamase, T. and Y. Tajima: MRSA inhibitors containing Keggin-type heteropolytungstate ions. Jpn. Kokai Tokkyo Koho, Horitoronikusu Kk, Japan; Yamase Toshihiro, Jp 08073362, (1996)
81. Tajima, Y: Detection of highly resistant strains of methicillin-resistant staphylococcus aureus using polyoxotungstates. Biomedical Research 23, 273-276 (2002)
82. Porte, D. Jr., R. S. Sherwin and A. Baron: Ellenberg & Rifkin's Diabetes Mellitus. McGraw Hill, New York, (2003)
83. Experimental Models of Diabetes. Ed: J. H. McNeill, CRC Press LLC, (1999)
84. Shechter, Y. and S. J. D. Karlish: Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 284, 556-558 (1980)
85. Meyerovitch, J., Z. Farfel, J. Sack and Y. Shechter: Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. Journal of Biological Chemistry 262, 6658-6662 (1987)
86. Heyliger, C. E., A. G. Tahiliani and J. H. McNeill: Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227, 1474-1477 (1985)
87. Crans, D. C., J. J. Smee, E. Gaidamauskas and L. Yang: The Chemistry and Biochemistry of Vanadium and the Biological Activities Exerted by Vanadium Compounds. Chemical Reviews 104, 849-902 (2004)
88. Thompson, K. H: Vanadium and diabetes. BioFactors 10, 43-51 (1999)
89. Sakurai, H., H. Yasui and Y. Adachi: The therapeutic potential of insulin-mimetic vanadium complexes. Expert Opinion on Investigational Drugs 12, 1189-1203 (2003)
90. Crans, D. C: Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds. Journal of Inorganic Biochemistry 80, 123-131 (2000)
91. Shechter, Y., I. Goldwaser, M. Mironchik, M. Fridkin and D. Gefel: Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium based drugs for diabetes. Coordination Chemistry Reviews 237, 3-11 (2003)
92. Goldwaser, I., D. Gefel, E. Gershonov, M. Fridkin and Y. Shechter: Insulin-like effects of vanadium: basic and clinical implications. Journal of Inorganic Biochemistry 80, 21-25 (2000)
93. Srivastava, A. K: Anti-diabetic and toxic effects of vanadium compounds. Molecular and Cellular Biochemistry 206, 177-182 (2000)
94. Thompson, K. H., J. H. McNeill and C. Orvig: Vanadium Compounds as Insulin Mimics. Chemical Reviews 99, 2561-2571 (1999)
95. Cam, M. C., R. W. Brownsey and J. H. McNeill: Mechanisms of vanadium action: insulinmimetic or insulin-enhancing agent? Canadian Journal of Physiology and Pharmacology 78, 829-847 (2000)
96. Goldfine, A. B., M.-E. Patti, L. Zuberi, B. J. Goldstein, R. LeBlanc, E. J. Landaker, Z. Y. Jiang, G. R. Willsky and C. R. Kahn: Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism, Clinical and Experimental 49, 400-410 (2000)
97. Boden, G., X. Chen, J. Ruiz, G. D. V. van Rossum and S. Turco: Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism, Clinical and Experimental 45, 1130-1135 (1996)
98. Fillat, C., J. E. Rodriguez-Gil and J. J. Guinovart: Molybdate and tungstate act like vanadate on glucose metabolism in isolated hepatocytes. Biochemical Journal 282, 659-663 (1992)
99. Munoz, M. C., A. Barbera, J. Dominguez, J. Fernandez-Alvarez, R. Gomis and J. J. Guinovart: Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats. Diabetes 50, 131-138 (2001)
100. Barbera, A., R. R. Gomis, N. Prats, J. E. Rodriguez-Gil, M. Domingo, R. Gomis and J. J. Guinovart: Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study. Diabetologia 44, 507-513 (2001)
101. Barbera, A., J. Fernandez-Alvarez, A. Truc, R. Gomis and J. J. Guinovart: Effects of tungstate in neonatally streptozotocin-induced diabetic rats: Mechanism leading to normalization of glycemia. Diabetologia 40, 143-149 (1997)
102. Fierabracci, V., V. De Tata, A. Pocai, M. Novelli, A. Barbera and P. Masiello: Oral tungstate treatment improves only transiently alteration of glucose metabolism in a new rat model of type 2 diabetes. Endocrine 19, 177-184 (2002)
103. Foster, J. D., S. E. Young, T. D. Brandt and R. C. Nordlie: Tungstate: a potent inhibitor of multifunctional glucose-6-phosphatase. Archives of Biochemistry and Biophysics 354, 125132 (1998)
104. Dominguez, J. E., M. C. Munoz, D. Zafra, I. Sanchez-Perez, S. Baque, M. Caron, C. Mercurio, A. Barbera, R. Perona, R. Gomis and J. J. Guinovart: The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway. Journal of Biological Chemistry 278, 42785-42794 (2003)
105. Fernandez-Alvarez, J., A. Barbera, B. Nadal, S. Barcelo-Batllori, S. Piquer, M. Claret, J. J. Guinovart and R. Gomis: Stable and functional regeneration of pancreatic beta-cell population in nSTZ-rats treated with tungstate. Diabetologia 47, 470-477 (2004)
106. Nomiya, K., H. Torii, T. Hasegawa, Y. Nemoto, K. Nomura, K. Hashino, M. Uchida, Y. Kato, K. Shimizu and M. Oda: Insulin mimetic effect of a tungstate cluster. Effect of oral administration of homo-polyoxotungstates and vanadium-substituted polyoxotungstates on blood glucose level of STZ mice. Journal of Inorganic Biochemistry 86, 657-667 (2001)
107. Cibert, C. and C. Jasmin: Determination of the intracellular localization of a polyoxotungstate (HPA-23) by Raman laser and x-fluorescence spectroscopies. Biochemical and Biophysical Research Communications 108, 1424-1433 (1982)
108. Lan, N., P. Greenspan, R. Gutman, C. Kelloes, M. A. Farmer and F. D. Boudinot: Cellular localization of antiviral polyoxometalates in J774 macrophages. Antiviral Research 32, 141148 (1996)
109. Domingo, J. L: Vanadium and tungsten derivatives as antidiabetic agents: A review of their toxic effects. Biological Trace Element Research 88, 97-112 (2002)
110. Tajima, Y: Tungstophosphate induced thromboembolic complications in vivo. Biomedical Research 24, 39-49 (2003)